s'authentifier
version française rss feed
Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France.
Scotet V., Duguépéroux I., Saliou P., Rault G., Roussey M., Audrézet M.-P., Férec C.
Orphanet Journal of Rare Diseases 7, 1 (2012) 14 - http://www.hal.inserm.fr/inserm-00681934
 (22380742) 
Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France.
Virginie Scotet () 1, Ingrid Duguépéroux1, 2, Philippe Saliou1, 2, Gilles Rault3, Michel Roussey4, 5, Marie-Pierre Audrézet1, 2, Claude Férec1, 2
1 :  Génétique, génomique fonctionnelle et biotechnologies
INSERM : U1078 – Université de Bretagne Occidentale [UBO] – EFS
EFS Bretagne, 46 rue Félix le Dantec 29218 Brest Cedex 2
France
2 :  Laboratoire de Génétique Moléculaire
CHU Brest – Hôpital Morvan
29200 Brest
France
3 :  CRCM - Centre de Ressources et de Compétences de la Mucoviscidose [Roscoff]
CRCM
29680 Roscoff
France
4 :  Centre de Ressources et de Compétences de la Mucoviscidose [Rennes]
CRCM
35000 Rennes
France
5 :  Association Française pour le Dépistage et la Prévention des Handicaps de l'Enfant
AFDPHE
75000 Paris
France
Lab-STICC_UBO_CACS_MOCS
ABSTRACT: BACKGROUND: Cystic fibrosis (CF) is an autosomal recessive disorder whose incidence has long been estimated as 1/2500 live births in Caucasians. Expanding implementation of newborn screening (NBS) programs now allows a better monitoring of the disease incidence, what is essential to make reliable predictions for disease management. This study assessed time trends in the birth incidence of CF over a long period (35 years: 1975-2009) in an area where CF is frequent (Brittany, France) and where NBS has been implemented for more than 20 years. METHODS: This study enrolled CF patients born in Brittany between January 1st 1975 and December 31st 2009 (n=483). Time trends in incidence were examined using Poisson regression and mainly expressed using the average percent change (APC). RESULTS: The average number of patients born each year declined from 18.6 in the late 1970's (period 1975-79) to 11.6 nowadays (period 2005-09). The corresponding incidence rates dropped from 1/1983 to 1/3268, which represented a decline close to 40% between these two periods (APC=-39.3%, 95% CI=-55.8% to -16.7%, p=0.0020). A clear breakpoint in incidence rate was observed at the end of the 1980's (p<0.0001). However, the incidence rate has remained quite stable since that time (annual APC=-1.0%, 95% CI=-3.0% to 1.1%, p=0.3516). CONCLUSIONS: This study provides an accurate picture of the evolution of the incidence of a genetic disease over a long period and highlights how it is influenced by the health policies implemented. We observed a 40% drop in incidence in our area which seems consecutive to the availability of prenatal diagnosis.
Sciences du Vivant/Génétique
Anglais
1750-1172

Articles dans des revues avec comité de lecture
10.1186/1750-1172-7-14
Orphanet Journal of Rare Diseases
Publisher BioMed Central
ISSN 1750-1172 
internationale
01/03/2012
01/03/2012
7
1
14

Cystic fibrosis – Incidence – Time trends – Newborn screening – Pregnancy ultrasound examination
This study was supported by a grant from the French Ministry of Health (PHRC 2007).
Liste des fichiers attachés à ce document : 
PDF
1750-1172-7-14.pdf(202.5 KB)
ANNEX
1750-1172-7-14.xml(62.4 KB)

tous les articles de la base du CCSd...